Independent analyses of commercial fish oil products reveal a significant quality control issue across the supplement industry: between 40–50% of sampled products exceed voluntary oxidation safety limits, measured by peroxide and anisidine values. These oxidation markers indicate lipid breakdown caused by exposure to heat, light, and oxygen during production and distribution.
Despite this widespread quality problem, human safety data remain limited. While preclinical models demonstrate potential harm at extreme oxidation levels, real-world evidence in humans is sparse. A single 2012 randomized controlled trial found no adverse effects from heavily oxidized fish oil in healthy adults over seven weeks, but long-term safety studies are absent.
The European Food Safety Authority acknowledges that current evidence does not establish clear health-based safety thresholds for oxidized fish oil. This gap between laboratory findings and clinical evidence leaves both healthcare providers and consumers uncertain about the true health implications of consuming oxidized omega-3 supplements. Read the full article on GMJ Newsroom.
Was this article helpful?
